Description
Added on the 20/09/2016 15:11:56 - Copyright : Wochit
The novel coronavirus pandemic has triggered a boom in telemedicine, by which patients receive medical care via telephone or computer. However, UPI reports a new study reveals the new paradigm isn't being adopted by everyone equally. UPI reports three groups of people have been far less likely to complete telemedicine appointments during the pandemic than others. Specifically, they're older adults, Asian Americans, and non-English speakers. Study co-author Dr. Srinath Adusumalli says many of these patients lack access to the necessary technology. Or, they are simply uncomfortable using it to complete medical appointments.
A new study reveals a COVID-19 vaccine under development in England safely promotes an immune response against the virus. According to UPI, the vaccine is in Phase 2 of clinical trials with Astra Zeneca, and is particularly effective in elderly recipients who are over age 70. Researchers say the finding of the 'robust' responses in older people in their study is both significant and encouraging. The populations at greatest risk of serious COVID-19 disease include people with existing health conditions and older adults. The so-called "Oxford vaccine," formally known as ChAdOx1 nCoV-19, is one of more than 120 being evaluated in response to the COVID-19 pandemic. To date, 48 of these vaccines have gotten into clinical trials to assess their safety and efficacy.
Democrat Sarah McBride has won the race for her state’s first Senate district. This means she will become the first openly transgender state senator in US history. McBride earned herself something of a national profile when she addressed the DNC in 2016. In her speech, she celebrated the chance to elect LGBT+ candidates across the country. McBride’s district is a solidly Democratic one, while Delaware at large is a reliably Democratic state. She joins several other trans leaders at a federal, national, and state level.
|
Support : Technical 
- Content 
- Editors 
